Publication Date:
2014
abstract:
n this issue of Blood, Colucci et al provide experimental data supporting the hypothesis that desmopressin (DDAVP) favors the hemostatic process not only by inducing the release of von Willebrand factor (VWF) from endothelial cells, but also by enhancing the procoagulant activity of platelets.1 © 2014 by The American Society of Hematology.
Iris type:
1.1 Articolo in rivista
Keywords:
Arginine Vasopressin; pharmacology, Blood Platelet Disorders; blood/drug therapy, Blood Platelets; drug effects/metabolism, Female, Humans, Male
List of contributors:
Pecci, Alessandro; Balduini, Carlo
Published in: